StonvexLoading…
StonvexStonvexStonvexCore line items from BAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $8.43B | $5.81B | $2.92B | $11.98B |
Operating Income | $770.00M | $540.00M | $257.00M | $1.37B |
Net Income | $646.00M | $446.00M | $271.00M | $935.00M |
EPS (Diluted) | $5.22 | $3.58 | $2.16 | $7.25 |
Total Assets | $7.05B | $7.15B | $7.17B | $7.31B |
Total Liabilities | $6.03B | $6.16B | $6.11B | $6.31B |
Cash & Equivalents | $882.00M | $816.00M | $711.00M | $885.00M |
Free Cash Flow OCF − CapEx | $739.00M | $491.00M | $96.00M | $911.00M |
Shares Outstanding | 120.86M | 122.03M | 123.71M | 124.88M |